Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00956501 · ClinicalTrials.gov registry record

Assessment of Postural Orientation and Equilibrium In Early Amyotrophic Lateral Sclerosis (ALS)

A clinical trial of Amyotrophic Lateral Sclerosis, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
35
Enrollment target
1
Study location

NCT00956501 is a study of Amyotrophic Lateral Sclerosis that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 35 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00956501, a study of Amyotrophic Lateral Sclerosis, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
35 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to characterize changes in postural orientation and equilibrium in early diagnosed ALS patient. The investigators plan to cross validate the use of a standardized test of equilibrium (EquiTest, Computerized Dynamic Posturography - CDP) in early diagnosed ALS patients.

Study Locations (1)

North Carolina

  • Carolinas ALS Clinical Research Center - Charlotte

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2009-02
Est. Completion 2011-02

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT00956501

The ClinicalTrials.gov registry entry for NCT00956501 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (96% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT00956501 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00956501 about?

NCT00956501 is a clinical study titled "Assessment of Postural Orientation and Equilibrium In Early Amyotrophic Lateral Sclerosis (ALS)". The purpose of this pilot study is to characterize changes in postural orientation and equilibrium in early diagnosed ALS patient. The investigators plan to cross validate the use of a standardized test of equilibrium (EquiTest, Computerized Dynamic Posturography - CDP) in early diagnosed ALS patien...

What is the current status of trial NCT00956501?

This trial is currently completed. The enrollment target is 35 participants. The study started on 2009-02. Estimated completion is 2011-02.

What conditions does trial NCT00956501 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.

Who is sponsoring clinical trial NCT00956501?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00956501 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.